Through a review of their structural characteristics, cargo capacity, behavior in clinical studies, and immune response, the article offers a practical overview for researchers looking to optimize the...
Read more
With this new donation, the study carried out by the Gene Therapy Group for the Central Nervous System, in collaboration with the La Lucha de Abril association, has received over €750,000 in donatio...
Read more
A research team at IDIBELL reveals the genetic events that cause blood stem cell depletion and how these accelerate leukaemia development in patients with GATA2
Read more
El trabajo desarrolla una nueva estrategia segura y eficaz para el trasplante de células madre hematopoyéticas que reemplaza la quimioterapia tradicional mediante una combinación de anticuerpos y a...
Read more
Advanced therapies, encompassing gene treatments, cell-based therapies, and tissue-engineered products, have marked a turning point in modern medicine. These innovations offer solutions for severe dis...
Read more
Biotechnology is rapidly transforming the pharmaceutical landscape—yet its industrialisation presents challenges that require coordinated technical, regulatory and strategic action.
Read more
Un nuevo protocolo sin quimioterapia logra injertos más seguros y eficaces en modelos de inmunodeficiencia y anemia por deficiencia de piruvato quinasa
Read more
Recognition underscores Miltenyi Biotec’s commitment to sustainability, complemented by strong EcoVadis performance and submission of near-term and long-term net-zero climate targets to the Science-...
Read more
Este hito es el resultado de la investigación en el uso de linfocitos modificados genéticamente para facilitar la eliminación de células tumorales, una alternativa más segura y eficiente que las ...
Read more
Tetraneuron has developed a gene therapy platform based on E2F4DN, a dominant-negative form of the transcription factor E2F4. According to the company, this is a revolutionary approach, as it acts at ...
Read more
The paper describes the case of a patient in whom, years after a bone marrow transplant, two immune cell lines corrected the original genetic defect.
Read more
ASPHALION is proud to be a partner in the ARDAT consortium, led by Pfizer and the University of Sheffield, and supported by Europe’s Innovative Medicines Initiative (IMI), which is jointly funded by...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
